Search all trials

Find therapies in clinical trials near you – page 10

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Acute myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study of Gilteritinib and Chemotherapy for Children, Adolescents, and Young Adults with Relapsed or Refractory Acute Myeloid Leukemia with FLT3 Mutation

Registered drugNo placebo

France

Participants:0–17 years · 18–64 years
Substances:Cytarabine

Contact Research Centre

Acute myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study on S65487 and Azacitidine for Adults with Untreated Acute Myeloid Leukemia Not Suitable for Intensive Treatment

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Acute myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study of Gilteritinib and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia with FLT3 Mutation in Patients Not Eligible for Intensive Chemotherapy

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Acute myeloid leukaemia

Not recruiting

Registered drug

Study of Venetoclax and Low Dose Cytarabine for Untreated Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Cytarabine

Contact Research Centre

Acute myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study of venetoclax and azacitidine treatment in adults with NPM1-mutated acute myeloid leukemia who experience molecular relapse or disease progression

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Acute myeloid leukaemia

Not recruiting

InvestigationalNo placebo

Study of Pivekimab Sunirine for Adults with CD123-positive Acute Myeloid Leukemia and Other CD123-positive Blood Cancers

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Pivekimab Sunirine

Contact Research Centre

Acute myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study of Cusatuzumab and Azacitidine for Patients with Newly Diagnosed Acute Myeloid Leukemia Not Eligible for Intensive Chemotherapy

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Acute myeloid leukaemia

Not recruiting

Registered drug

Study of Venetoclax and Azacitidine for Patients with Untreated Acute Myeloid Leukemia Who Cannot Have Standard Induction Therapy

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Acute myeloid leukaemia+1

Not recruiting

Registered drugNo placebo

Study of MP0533 for Patients with Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Using Sodium Dihydrogen Phosphate Dihydrate, Polysorbate 20, and Sodium Chloride

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Acute myeloid leukaemia+1

Not recruiting

InvestigationalNo placebo

Study of NMS-03592088 for Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML)

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Nms-03592088

Contact Research Centre

Acute myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study of Venetoclax and Azacitidine for Patients with Acute Myeloid Leukemia After Stem Cell Transplant

Registered drugNo placebo

Czechia

Participants:0–17 years · 18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Acute myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study of Venetoclax and Azacitidine for Adults 18+ with Acute Myeloid Leukemia Not Eligible for Standard Therapy

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Find therapies in clinical trials near you – page 10

132 trials match your criteria

Acute myeloid leukaemia

Study of Gilteritinib and Chemotherapy for Children, Adolescents, and Young Adults with Relapsed or Refractory Acute Myeloid Leukemia with FLT3 Mutation

Acute myeloid leukaemia

Study on S65487 and Azacitidine for Adults with Untreated Acute Myeloid Leukemia Not Suitable for Intensive Treatment

Acute myeloid leukaemia

Study of Gilteritinib and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia with FLT3 Mutation in Patients Not Eligible for Intensive Chemotherapy

Acute myeloid leukaemia

Study of Venetoclax and Low Dose Cytarabine for Untreated Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy

Acute myeloid leukaemia

Study of venetoclax and azacitidine treatment in adults with NPM1-mutated acute myeloid leukemia who experience molecular relapse or disease progression

Acute myeloid leukaemia

Study of Pivekimab Sunirine for Adults with CD123-positive Acute Myeloid Leukemia and Other CD123-positive Blood Cancers

Acute myeloid leukaemia

Study of Cusatuzumab and Azacitidine for Patients with Newly Diagnosed Acute Myeloid Leukemia Not Eligible for Intensive Chemotherapy

Acute myeloid leukaemia

Study of Venetoclax and Azacitidine for Patients with Untreated Acute Myeloid Leukemia Who Cannot Have Standard Induction Therapy

Acute myeloid leukaemia+1

Study of MP0533 for Patients with Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Using Sodium Dihydrogen Phosphate Dihydrate, Polysorbate 20, and Sodium Chloride

Acute myeloid leukaemia+1

Study of NMS-03592088 for Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML)

Acute myeloid leukaemia

Study of Venetoclax and Azacitidine for Patients with Acute Myeloid Leukemia After Stem Cell Transplant

Acute myeloid leukaemia

Study of Venetoclax and Azacitidine for Adults 18+ with Acute Myeloid Leukemia Not Eligible for Standard Therapy

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.